Bio-Corn Products company information, Employees & Contact Information

Biocon gets USFDA's tentative approval for antibacterial drug Rifaximin Business Standard

Bone Health: Biocon Biologics Receives Positive CHMP Opinions for Biosimilar Denosumab in Europe PR Newswire UK

Biocon Biologics gets UK drug regulator nod for Denosumab biosimilars — Vevzuo and Evfraxy CNBC TV18

Biocon appoints Rajesh Umakant Shanoy as Company Secretary, Compliance Officer Medical Dialogues

Biocon launches diabetes, obesity management drug in UK The Economic Times

Biocon Shares Gain 1% as Subsidiary Secures Approval from UK MHRA Equitypandit

Biocon Biologics secures USFDA approval for Bosaya and Aukelso biosimilars Business Standard

Biocon Biologics Secures Market Entry for Bmab 1200, a Proposed Biosimilar to Stelara®, in Europe, UK, Canada, and Japan PR Newswire

BOARD OF DIRECTORS Biocon

Biocon accused of committing IP theft to create cancer biotech Bicara Fierce Biotech

Biocon Biologics partners with US non-profit co to make diabetes treatment cheaper for Americans CNBC TV18

Biocon appoints Ekta Agarwal as Interim Company Secretary, Compliance Officer Medical Dialogues

Biocon Biologics secures multiple market access coverage for Yesintek in US Business Standard

Biocon Shares Slip 4% on Launching Liraglutide in the UK Equitypandit

Legacy - Biocon - Global Biopharmaceutical company Biocon

Karnataka CM's remark on Covid vaccines 'factually incorrect': Biocon chief Business Standard

Investors Biocon

Biocon share rises as arm secures UK MHRA nod for plaque psoriasis drug Business Standard

Biocon Biologics marks one year as global biosimilars enterprise Business Standard

USFDA approves Biocon Biologics' biosimilar for Crohn's disease, psoriasis Business Standard

KEY MANAGEMENT TEAM Biocon

MANUFACTURING OPERATIONS Biocon

Biocon Q2FY25 Revenue at Rs 3,623 Cr, EBITDA at Rs 718 Cr Biocon

Partners - Biocon - Global Biopharmaceutical company Biocon

WORKING WITH US Biocon

Functions - Biocon - Global Biopharmaceutical company Biocon

India's Biocon developing its own version of Wegovy, clinical trial likely next year Reuters

After Five Years of Successful Experience Internationally, Biocon Biologics’ Hulio® Biosimilar to Humira®, Now Available in the United States Biocon

RESEARCH & DEVELOPMENT Biocon

Biocon Q4FY24 Revenue at Rs 3,966 Cr, EBITDA at Rs 964 Cr; Net Profit (before exceptional items) at Rs 144 Cr Biocon

Biocon is targeting to be a gender parity company by 2030, says Kiran Mazumdar Shaw Storyboard18

Biocon inaugurates first manufacturing facility in New Jersey's Cranbury Business Standard

BOARD OF DIRECTORS Biocon

Who we are Biocon

Biocon Malaysia - Asia’s largest insulin manufacturing and R&D facility Biocon

Biocon Q4FY25 Revenue at Rs 4,454 Cr, Up 15%** EBITDA at Rs 1,115 Cr; Up 16%; Net Profit at Rs 344 Cr, Up 153% Biocon

Biocon Biologics Announces New Dermatology Data to Be Presented at EADV Congress 2024 PR Newswire UK

OUR KEY PRIORITIES Biocon

Biocon Biologics gets marketing nods in UK for Vevzuo, Evfraxy Medical Dialogues

Bicara debuts with $40M from Biocon to bankroll bifunctional antibodies Fierce Biotech

Siddaramaiah, Biocon Chief Spar Over Covid Vaccine Remarks Amid Hassan Heart Attack Probe Deccan Herald

Biocon Q3FY25 Revenue at Rs 3,856 Cr, Up 7%# EBITDA at Rs 787 Cr, Up 16%#; Net Profit at Rs 25 Cr Biocon

Biocon Biologics expands diabetes portfolio with FDA approval for Kirsty Business Standard

Mylan and Biocon launch new insulin glargine biosimilar in the UK News-Medical

A Century of Insulins - Biocon - Global Biopharmaceutical company Biocon

Biocon sees mid-teens revenue growth on biosimilars, generics push Mint

Biocon Biologics gets UK MHRA nod for biosimilars Vevzuo, Evfraxy The Economic Times

Biocon's growth formula: Generics & biosimilars Times of India

Biocon launches Liraglutide for diabetes, obesity in UK Medical Dialogues

Biocon subsidiary acquires Viatris pharma for $3 billion Mint

Is Now The Time To Put Biocon (NSE:BIOCON) On Your Watchlist? simplywall.st

Biocon to sell stake in biosimilar arm and Syngene: Sources The Economic Times

Biocon acquires Eywa Pharma's US-based manufacturing facility for $7.7 mn Business Standard

Biocon Biologics refinances $1.1 bn debt through bonds, syndicated facility Business Standard

No immediate plans for further stake sales or Biocon Biologics IPO: CEO Siddharth Mittal CNBC TV18

Biocon leads India's push into blockbuster weight-loss drugs as patents for Saxenda, Wegovy and Ozempic set to expire Mint

Biocon biologics receives marketing approval by MHRA for YESAFILI in UK Business Standard

Biocon Ranked Among Global Top Ten Biotech Employers; The only Asian Company to Feature in 2016 Rankings Biocon moves up to No. 9 from No. 13 last year Biocon

Biocon Biologics announces getting US FDA approval for eye treatment drug Business Standard

Biocon Biologics secures deal with Janssen to launch biosimilar Bmab 1200 Business Standard

Biocon inks licensing, supply pact with Tabuk Pharmaceutical Manufacturing Business Standard

Biocon leads India's push into anti-obesity drugs as patents lapse Business Standard

Biocon gets MHRA UK approval for marketing Denosumab biosimilars 'Vevzuo' & 'Evfraxy' Business Standard

Biocon Biologics gets green light to launch Yesafili biosimilar in Canada Business Standard

Biocon launches generic Liraglutide in the UK for diabetes, obesity treatment CNBC TV18

Biocon Biologics Secures UK Approval for Two Denosumab Biosimilars scanx.trade

Biocon launches GLP-1 peptide, Liraglutide in the UK Business Standard

Biocon shares in focus as company inaugurates first manufacturing facility in the US Upstox

Start-up Stories: Kiran Mazumdar-Shaw BBC

F&O Strategy: Manappuram Finance to Biocon— Rupak De suggests buy or sell strategy for THESE stocks - 16 June Mint

'They were not comfortable about hiring a woman' BBC

Biocon share price target 2024: Pharma company bags Rs 1,242 cr deal; Time to BUY? ET Now

Biocon Ltd Share Price Today, BIOCON Share Price NSE, BSE Business Today

Biocon Inks Co-Development & Commercialization Agreement with Lab PiSA for rh- Insulin in USA BioTecNika

Eldoret family turns maize cobs into jet fuel additive Business Daily

Companies registered under EPZ Kenya, their products, and contact info Tuko News